Sanofi

Sanofi received a score of 100 on the 2026 Corporate Equality Index (CEI) from the Human Rights Campaign (HRC), a political stakeholder group. The company recruits employees based on sexual identity issues. The company discriminates against vendors that do not promote divisive sex and gender policies, indicating it prioritizes sexual issues over merit (1)(2)(3). Sanofi received a score of 100 on the 2025 Corporate Equality Index (CEI) from the Human Rights Campaign (HRC), a political stakeholder group. The company recruits employees based on sexual identity issues. The company discriminates against vendors that do not promote divisive sex and gender policies, indicating it prioritizes sexual issues over merit (4)(5). Sanofi was a member of the Global Alliance for Responsible Media, which demonetized and suppressed content that it deemed to spread “hate speech” or “misinformation”, discuss “debated social issues in a negative or partisan context”, or “vilif[y]” individuals based on sexual orientation and gender identity. These arbitrary guidelines were used to censor mainstream perspectives online (6)(7)(8). The company promotes divisive sex and gender policies. Its Suppliers Code of Conduct requires international vendors to include sexual orientation and gender identity in their nondiscrimination policy (9). Sanofi integrates ESG into its business practices. From its Suppliers Code of Conduct: “Suppliers measure and report their carbon footprint and greenhouse gases emissions and pledge to voluntarily reduce them” (10). However, Sanofi has not publicly canceled customers, suppliers, or vendors based on political views or religious beliefs (11).

Sanofi’s HRC 2026 CEI rating indicates the company will not donate to non-religious charities unless they embrace controversial sexual identity policies (1)(2)(3). Sanofi’s HRC 2025 CEI rating indicates the company will not donate to non-religious charities unless they embrace controversial sexual identity policies (4)(5). The company does not discriminate against charitable organizations based on views or beliefs (6)(7).

Sanofi’s HRC 2026 CEI rating indicates the company forces employees to attend at least one, controversial training on gender identity, sexual orientation, transgender issues, and divisive racial ideology. The company provides gender transition guidelines for its employees and a specific benefits guide with a comprehensive explanation of transgender services funded by the company (1)(2)(3). Sanofi’s HRC 2025 CEI rating indicates the company forces employees to attend multiple, controversial trainings on gender identity, sexual orientation, transgender issues, and divisive racial ideology. The company provides gender transition guidelines for its employees and a specific benefits guide with a comprehensive explanation of transgender services funded by the company (4)(5). The company appears to prioritize diversity over merit in its recruitment. From its 2024 Sustainability Statement: “Sanofi has a direct impact on diversity amongst its workforce through its diversity recruitment policies…” (6). The company appears to prioritize diversity over merit in its leadership composition. From its 2024 Sustainability Statement: “We are driven to make our workplace and communities inclusive and diverse by: achieving gender representation in senior leadership;” (7). In January 2024 America First Legal filed a letter with the EEOC requesting a civil rights investigation into the company over discriminatory practices in hiring and promotion. However, in September 2024, Sanofi agreed to end its “race and sex-based quotas for hiring and promotions” (8)(9)(10). Sanofi’s former CEO Paul Hudson signed Catalyst’s Champions for Change pledge, indicating its support of DEI in its leadership composition through the establishment of gender and racial targets (11)(12). The company offers diversity training for all its employees (13). The company protects its employees against viewpoint discrimination (14).

Sanofi’s HRC 2026 CEI rating indicates the company potentially agrees to allow a controversial stakeholder group focused on sexual identity issues to dictate marketing or advertising strategy. By doing so, the company risks dividing employees, alienating customers and harming shareholders (1)(2)(3). Sanofi’s HRC 2025 CEI rating indicates the company agrees to allow a controversial stakeholder group focused on sexual identity issues to dictate marketing or advertising strategy. By doing so, the company risks dividing employees, alienating customers and harming shareholders (4)(5). Sanofi signed an open letter endorsing the Equality Act, a contentious proposal to amend the 1964 Civil Rights Act by adding sexual orientation and so-called gender identity as protected categories. The legislation would, among other implications, grant biological men access to women-only spaces such as sports teams and public restrooms, and compel healthcare providers to deliver sex-denying healthcare and offers diversity training for all its employees (6). The company denounced Florida’s law that prevents public schools from teaching young children about gender identity and sexuality (7). The company was a signatory of the Health Sector Climate Pledge, committing itself to achieve net zero emissions by 2050. Signatories were expected to develop and release a climate resilience plan and appoint a corporate executive to oversee its implementation (8). Sanofi’s former CEO, Bill Sibold signed the CEO Action for Diversity & Inclusion pledge, which includes a commitment to promote DEI through bias education training in the workplace, strategize on DEI programs/initiatives with other signatories, and engage boards of directors when developing and evaluating DEI strategies (9)(10). The company was a contributing member of GARM’s Action Guide to Reduce Media Greenhouse Gas Emissions and The Global Media Sustainability Framework which provide an action plan for media companies to transition to net zero greenhouse gas emissions (11)(12). Sanofi supports DEI within its business practices. From its 2024 Sustainability Statement: “To gain an edge in the competitive talent market, we have created a “Fit for Future” career site that reflects our brand, culture, and DE&I (Diversity, Equity & Inclusion) ambitions” (13). The company supports ESG within its business practices. From its 2024 Sustainability Statement: “Risks and uncertainties include among other things, Sanofi’s ability to successfully implement its ESG efforts or meet its goals, targets and objectives, or whether the changes it implements in connection with its ESG efforts generate the intended effects” (14). Sanofi scored a 100 out of 100 on the 2023-2024 Corporate Equality Index (CEI) from the Human Rights Campaign (HRC), a political stakeholder group (15)(16).

Sanofi’s HRC 2026 CEI rating indicates the company covers transgender related costs for its employees and their children, including paid short-term leave, puberty blockers, cross-sex hormones, chest surgeries, genital surgeries, medical visits, lab monitoring, and mental health benefits. The company also covers at least five of the following services: reconstructive hair removal, cosmetic hair removal, tracheal shave or reduction, facial surgeries, voice modification surgery, voice modification therapy, lipoplasty or filling for body masculinization or feminization, and travel and lodging expenses. Additionally, the company has potentially pledged philanthropic support of at least one organization or event that promotes sex and gender ideology. By allowing a political stakeholder group to dictate operations, the company increases health care costs and risks dividing employees, alienating customers and harming shareholders (1)(2)(3)(4). Sanofi’s HRC 2025 CEI rating indicates the company covers transgender related costs for its employees and their children, including paid short-term leave, puberty blockers, cross-sex hormones, chest surgeries, genital surgeries, medical visits and lab monitoring, travel and lodging. Additionally, the company has pledged philanthropic support of at least one organization or event that promotes sex and gender ideology. By allowing a political stakeholder group to dictate operations, the company increases health care costs and risks dividing employees, alienating customers and harming shareholders (5)(6). The company provides a benefits package for employees that covers travel/lodging costs for an abortion and transgender medical procedures for covered employees and dependents, including children (7)(8)(9). Sanofi was a member of the Global Alliance for Responsible Media and is a corporate partner of the National LGBT Chamber of Commerce (10)(11)(12)(13). The company sponsored WorldPride 2025 (14). Otherwise, there are no publicly known cases of Sanofi using corporate funds to advance ideological causes, organizations, or policies (15).

Sanofi‘s HRC 2025 CEI rating indicates the company publicly advocated for controversial sex and gender ideology through local, state or federal legislation or initiatives. By allowing a political stakeholder group to dictate operations, the company risks dividing employees, alienating customers and harming shareholders (1)(2). Sanofi has not used its PAC donations or lobbying for ideological purposes (3)(4)(5).